HA, a major extracellular matrix component, is a physiological ligand that is overexpressed in CD44 on the surface of malignant tumor cells and can be used to selectively activate multiple oncogenic signaling pathways that lead to tumor cell-specific phenotypes [45]. This evidence concerns the gene CD44 and neoplasm.